DWTX · Dogwood Therapeutics Inc
United States · RS rating 13 · As of 2026-10-14
| Price | 1.27 USD |
|---|---|
| 1-day change | -2.3% |
| RS rating (overall / 1M / 3M / 12M) | 13 / 8 / 38 / 6 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 25 / 12 / 52 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +96.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +81.4% |
| Market cap (USD) | $46.8M |